BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16784406)

  • 1. Biomarkers in Parkinson's disease.
    Dorsey ER; Holloway RG; Ravina BM
    Expert Rev Neurother; 2006 Jun; 6(6):823-31. PubMed ID: 16784406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers for Parkinson's [corrected] disease: tools to assess Parkinson's disease onset and progression.
    Marek K; Jennings D; Tamagnan G; Seibyl J
    Ann Neurol; 2008 Dec; 64 Suppl 2():S111-21. PubMed ID: 19127587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Parkinson's disease biomarkers.
    Prakash KM; Tan EK
    Expert Rev Neurother; 2010 Dec; 10(12):1811-25. PubMed ID: 21091313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers for Parkinson's disease.
    Graeber MB
    Exp Neurol; 2009 Apr; 216(2):249-53. PubMed ID: 19166835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The search for biomarkers in Parkinson's disease: a critical review.
    Antoniades CA; Barker RA
    Expert Rev Neurother; 2008 Dec; 8(12):1841-52. PubMed ID: 19086880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarkers for Parkinson's disease.
    Sherer TB
    Sci Transl Med; 2011 Apr; 3(79):79ps14. PubMed ID: 21508309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers for the early detection of Parkinson's and Alzheimer's disease.
    Berg D
    Neurodegener Dis; 2008; 5(3-4):133-6. PubMed ID: 18322370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers in Huntington's and Parkinson's Disease.
    O'Keeffe GC; Michell AW; Barker RA
    Ann N Y Acad Sci; 2009 Oct; 1180():97-110. PubMed ID: 19906264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers of neurodegenerative disorders: how good are they?
    Rachakonda V; Pan TH; LE WD
    Cell Res; 2004 Oct; 14(5):347-58. PubMed ID: 15538967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early detection of Parkinson's disease: unmet needs.
    Gerlach M; Hendrich A; Hueber R; Jost W; Winkler J; Woitalla D; Riederer P
    Neurodegener Dis; 2008; 5(3-4):137-9. PubMed ID: 18322371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers for the diagnosis and management of Parkinson's disease.
    Waragai M; Sekiyama K; Fujita M; Tokuda T; Hashimoto M
    Expert Opin Med Diagn; 2013 Jan; 7(1):71-83. PubMed ID: 23530844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers in Parkinson's disease: an update.
    Shtilbans A; Henchcliffe C
    Curr Opin Neurol; 2012 Aug; 25(4):460-5. PubMed ID: 22772875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetranectin and apolipoprotein A-I in cerebrospinal fluid as potential biomarkers for Parkinson's disease.
    Wang ES; Sun Y; Guo JG; Gao X; Hu JW; Zhou L; Hu J; Jiang CC
    Acta Neurol Scand; 2010 Nov; 122(5):350-9. PubMed ID: 20085559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploiting the potential of molecular profiling in Parkinson's disease: current practice and future probabilities.
    Mellick GD; Silburn PA; Sutherland GT; Siebert GA
    Expert Rev Mol Diagn; 2010 Nov; 10(8):1035-50. PubMed ID: 21080820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Network biomarkers for the diagnosis and treatment of movement disorders.
    Poston KL; Eidelberg D
    Neurobiol Dis; 2009 Aug; 35(2):141-7. PubMed ID: 19013242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cerebrospinal fluid biomarkers for the early diagnosis of Parkinson's disease].
    da Costa AG; Gago MF; Garrett C
    Acta Med Port; 2011 Dec; 24 Suppl 4():761-8. PubMed ID: 22863482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can we image premotor Parkinson disease?
    Marek K; Jennings D
    Neurology; 2009 Feb; 72(7 Suppl):S21-6. PubMed ID: 19221310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomics tools for identifying biomarkers for neuropsychiatric diseases.
    Quinones MP; Kaddurah-Daouk R
    Neurobiol Dis; 2009 Aug; 35(2):165-76. PubMed ID: 19303440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson's disease.
    Goldknopf IL; Sheta EA; Bryson J; Folsom B; Wilson C; Duty J; Yen AA; Appel SH
    Biochem Biophys Res Commun; 2006 Apr; 342(4):1034-9. PubMed ID: 16516157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene and protein signatures in sporadic Parkinson's disease and a novel genetic model of PD.
    Mandel SA; Fishman T; Youdim MB
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S242-7. PubMed ID: 18267243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.